(1)
Molecular Docking Studies of Schiff Bases With Azetidinone Against Dihydrofolate Reductase Enzyme As Potential Anti-Cancer Agents. AJP 2024, 18 (02). https://doi.org/10.22377/ajp.v18i02.5480.